Al Sayed Sallam (Al-Sayed Sallam)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Methicillin Resistant Staphylococcus Aureus

Nitric Oxide Synthase

Knee Osteoarthritis

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Samar Zuhair Alshawwa, Thanaa A El-Masry, Engy Elekhnawy, Hadil Faris Alotaibi, Al Sayed Sallam, Dalia H Abdelkader
Fabrication of Celecoxib PVP Microparticles Stabilized by Gelucire 48/16 via Electrospraying for Enhanced Anti-Inflammatory Action. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Samar Zuhair Alshawwa, Thanaa A El-Masry, Mohamed Nasr, Ahmed Y Kira, Hadil Faris Alotaibi, Al Sayed Sallam, Engy Elekhnawy
Celecoxib-Loaded Cubosomal Nanoparticles as a Therapeutic Approach for Staphylococcus aureus In Vivo Infection. Microorganisms 11 (9) (2023)
Khaled H Al Zahabi, Hind Ben Tkhayat, Ehab Abu-Basha, Al Sayed Sallam, Husam M Younes
Formulation of Lipid-Based Tableted Spray-Congealed Microparticles for Sustained Release of Vildagliptin: In Vitro and In Vivo Studies. Pharmaceutics 13 (12) (2021)
Omaima N Najib, Gary P Martin, Stewart B Kirton, Michelle J Botha, Al Sayed Sallam, Darragh Murnane
The Influence of Oily Vehicle Composition and Vehicle-Membrane Interactions on the Diffusion of Model Permeants across Barrier Membranes. Membranes 11 (1) (2021)